IFP Advisors’s Elevai Labs ELAB Stock Holding History

IFP Advisors’s Portfolio ELAB Stock Details ELAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21K	Sell	100 -100	-50%	-$2.53K	﹤0.01%	4442
2026 Q1	$12K	Buy	+200	New	+$25.6K	﹤0.01%	3065

Other funds holding ELAB

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

IFP Advisors's ELAB Position: Q2 2026 in Review

IFP Advisors reduced its Elevai Labs (ELAB) stake by 50% in Q2 2026, selling an estimated $2.53K and leaving 100 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #4442.

IFP Advisors first reported a position in ELAB in Q1 2026 and has held it in 2 quarters since. The position peaked at $12K in Q1 2026. 11 funds tracked by Wall St. Rank hold ELAB as of Q2 2026.

IFP Advisors held 100 shares of Elevai Labs worth $1.21K as of Q2 2026.
IFP Advisors sold 100 Elevai Labs shares in Q2 2026, an estimated $2.53K.
Elevai Labs made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4442 holding.
IFP Advisors first reported a position in Elevai Labs in Q1 2026 and has held it in 2 quarters since.
IFP Advisors's Elevai Labs position peaked at $12K in Q1 2026.
11 funds tracked by Wall St. Rank held Elevai Labs as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.